R7

General Information


DRACP ID  DRACP00246

Peptide Name   R7

Sequence  RRRRRRR

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2.2.15 Hepatoblastoma Blastoma Not active up to 1 mM CellTiter 96 AQueous One Solution assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00246

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C42H86N28O8

Absent amino acids  ACDEFGHIKLMNPQSTVWY

Common amino acids  R

Mass  121850

Pl  13.28

Basic residues  7

Acidic residues  0

Hydrophobic residues  0

Net charge  7

Boman Index  -10444

Hydrophobicity  -450

Aliphatic Index  0

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21144865

Title  Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production

Doi 10.1016/j.antiviral.2010.12.001

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.